The present disclosure provides compounds and methods for inhibiting the interaction of menin with its upstream or downstream signaling molecules including but not limited to MLL1, MLL2 and MLL-fusion oncoproteins. Compounds of the disclosure may be used in methods for the treatment of a wide variety of cancers and other diseases associated with one or more of MLL1, MLL2, MLL fusion proteins, and menin.
本公开提供了抑制 menin 与其上游或下游信号分子(包括但不限于 MLL1、ML
L2 和 MLL 融合肿瘤蛋白)相互作用的化合物和方法。本公开的化合物可用于治疗与 MLL1、ML
L2、MLL 融合蛋白和 menin 中的一种或多种相关的多种癌症和其它疾病。